What Is Ozempic (Semaglutide)?
The first GLP-1 receptor agonist to receive a license to treat type 2 diabetes became semaglutide under the brand name Ozempic. It also acts the same way as the natural hormone of the body, GLP-1, since insulin prevents the glucagon, slows the emptying of the stomach, and lessens the appetite. The treatments do not aid individuals in...
Gold subscription required
The Lifestyle category is available to Gold subscribers and above.
Subscribe — from $4.99/moAlready a subscriber? Log in
